BioNxt Solutions Inc.
BNXT
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -50.93% | 39.00% | 35.56% | -73.04% | 40.36% |
| Total Depreciation and Amortization | 1.20% | -2.91% | -45.57% | -12.47% | -11.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 44.24% | 27.34% | -45.24% | 33.71% | -64.44% |
| Change in Net Operating Assets | 906.22% | -129.18% | -52.35% | 1,345.61% | -132.92% |
| Cash from Operations | 68.38% | 27.04% | 23.11% | -18.54% | 10.60% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -100.00% | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -1.09% | 95.81% |
| Issuance of Common Stock | -100.00% | 23.05% | -18.58% | -35.28% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 29.64% | 34.61% | 19.47% | -- |
| Cash from Financing | -100.00% | 25.74% | -15.13% | -37.80% | 706.85% |
| Foreign Exchange rate Adjustments | 250.00% | 100.00% | -94.44% | 250.00% | 33.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -201.45% | 179.57% | -20.24% | -192.28% | 116.33% |
